Med Spa EBITDA Valuation Multiples: What Buyers Are Paying in 2024
Current market data on how medical aesthetic businesses are priced, what drives premium multiples, and what tanks valuations in lower middle market deals.
Med spas in the $1M–$5M revenue range typically trade at 3.5x–6x EBITDA, with premium multiples reserved for businesses with membership revenue, non-owner-dependent provider teams, and clean compliance histories. Key-person risk, deferred revenue liabilities, and state CPOM complexity are the most common valuation discount factors buyers apply during due diligence.
Med Spa EBITDA Multiple Ranges by Tier
| Business Tier | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Distressed or High-Risk | $300K–$500K | 3.0x–3.5x | Owner is primary injector, declining revenue, compliance issues, or weak financial documentation. Buyers price in significant transition and regulatory risk. |
| Standard Owner-Operated | $400K–$700K | 3.5x–4.5x | Stable revenue, some membership base, but owner-dependent. Clean books. Moderate provider team in place. SBA 7(a) financing typically used. |
| Growth-Stage with Systems | $600K–$900K | 4.5x–5.5x | 200+ active members, diversified service mix, employed provider team, strong Google reputation, and documented patient retention metrics. |
| Platform-Ready or PE Target | $800K+ | 5.5x–6.5x | Scalable multi-location model, non-owner-operator, high membership density, CPOM-compliant entity structure, and strong revenue growth trajectory. |
What Drives Med Spa Multiples
Owner Provider Dependency
Negative — up to 1.5x multiple reduction impactWhen the owner performs the majority of injections, buyers discount heavily. A fully staffed provider team with independent client relationships commands premium pricing.
Membership Revenue Penetration
Positive — up to 1.0x multiple premium impactMed spas with 200+ active recurring members demonstrate predictable monthly cash flow that PE buyers and SBA lenders reward with higher valuations.
CPOM Compliance Structure
Positive or Disqualifying impactA properly structured medical director agreement and MSA entity separation removes a key acquisition barrier. Non-compliant structures can kill deals entirely in regulated states.
Equipment Age and CapEx Requirements
Negative — reduces adjusted EBITDA impactOutdated laser or body contouring devices requiring near-term replacement are treated as deferred capital costs, reducing effective EBITDA and compressing buyer multiples.
Geographic Market and Demographics
Positive — up to 0.5x premium impactHigh-income suburban markets with limited competition and strong Google review velocity support premium pricing and faster patient acquisition post-close.
Recent Market Trends
PE-backed aesthetics roll-up platforms have intensified competition for platform-ready med spas with $800K+ EBITDA, pushing top-tier multiples above 6x in competitive processes. SBA lending remains active for sub-$750K EBITDA deals. Buyers are increasingly scrutinizing deferred revenue liabilities from oversold memberships and package balances, which can meaningfully reduce net seller proceeds at closing.
Sample Med Spa Transactions
Owner-operated injectable-focused med spa, suburban Texas market, 150 active members, owner performing 60% of treatments, clean books
$420K
EBITDA
3.8x
Multiple
$1.6M
Price
Systems-driven med spa, Southeast market, 280 active members, three employed injectors, diversified laser and body contouring services
$680K
EBITDA
5.1x
Multiple
$3.47M
Price
Multi-location aesthetics platform, Midwest, non-owner-operator, 500+ members, CPOM-compliant MSA structure, PE roll-up add-on acquisition
$1.1M
EBITDA
6.0x
Multiple
$6.6M
Price
EBITDA Valuation Estimator
Get your Med Spa business value range instantly
Industry: Med Spa · Multiples based on 3.5x–4.5x (Standard Owner-Operated)
Powered by Deal Flow OS
dealflow-os.com · Free M&A tools for every stage of the deal
Frequently Asked Questions
What EBITDA multiple should I expect when selling my med spa in 2024?
Most lower middle market med spas sell at 3.5x–6x EBITDA. Where you land depends on membership revenue, provider team independence, compliance structure, and documented patient retention metrics.
Does SBA financing affect how buyers value a med spa?
Yes. SBA 7(a) loans cap around $5M, which anchors pricing for sub-$1M EBITDA deals. Buyers using SBA financing often target 3.5x–4.5x multiples to ensure debt service coverage ratios qualify.
How does a membership program increase my med spa's valuation?
Recurring membership revenue reduces buyer risk and improves cash flow predictability. Med spas with 200+ active members typically earn 0.5x–1.0x higher EBITDA multiples than purely transactional competitors.
Why does corporate practice of medicine compliance matter to valuation?
CPOM non-compliance can terminate a deal or force costly restructuring post-LOI. Sellers with a properly documented medical director agreement and MSA entity structure attract more buyers and command stronger multiples.
More Med Spa Guides
Find Med Spa businesses at the right price
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
Start finding deals — freeNo credit card required